Medical Letter on the CDC and FDA
Susan Hasty, Publisher
Table of Contents . . . January 13th, 2008
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Medical Letter on the CDC and FDA | Other Publications
Drug Resistance - Pfizer Receives Approvable Letter from FDA for Dalbavancin
Peripheral T-Cell Lymphoma - Status:
Cancer Gene Therapy - Data on cancer gene therapy discussed by K. Grønbaek and colleagues
Nanospheres - Researchers from Gwangju Institute of Science and Technology detail new studies and findings in the area of nanospheres
Anthrax - Studies from H.F. Duan and co-researchers update current data on anthrax
Chemical Warfare - Data from University of Oxford provide new insights into chemical warfare
Human Papillomavirus Vaccines - New data from Creighton University illuminate research in human papillomavirus vaccines
Life Sciences - Studies in the area of life sciences reported from Wadsworth Center
Pressure Ulcer - Data from Case Western Reserve University advance knowledge in pressure ulcer
Prostatitis - New prostatitis study findings recently were published by researchers at University of Montreal
Pyroptosis - Study results from University of Ryukyus provide new insights into pyroptosis
Clinical Syndrome - New findings from Nihon University in the area of clinical syndrome described
DNA Vaccines - Studies from Oregon State University, Department of Pharmaceutical Sciences in the area of DNA vaccines published
Hantavirus - Reports on hantavirus findings from Beijing Institute of Microbiology and Epidemiology provide new insights
Immunology - New findings reported from National Institute of Allergy and Infectious Disease describe advances in immunology
Immunology - New immunology research from University of Washington, Department of Medicine outlined
Life Sciences - New findings in life sciences described from National Blood Service
Malnutrition Therapy - Scientists at University of Southampton, Institute of Human Nutrition detail research in malnutrition therapy
Monoclonal Antibodies - Research reports from National Health Service provide new insights into monoclonal antibodies
Parvovirus - Researchers' work from National Institute for Biological Standards and Control focuses on parvovirus
Thrombocytopenia - Research reports on thrombocytopenia from National Institute for Biological Standards and Control provide new insights
Thrombocytopenia Genetics - Research on thrombocytopenia genetics discussed by scientists at National Health Service
Vaccines - Researchers at Institute of Microbiology and Epidemiology target vaccines
AspenBio Pharma, Inc. - AspenBio Pharma Closes $18.2 Million Private Placement of Common Stock
Drug Development - Salix Pharmaceuticals Announces Submission of Granulated Mesalamine New Drug Application
Fibromyalgia - Forest and Cypress Announce Submission of New Drug Application for Milnacipran for the Treatment of Fibromyalgia Syndrome
HIV/AIDS - Ardea Biosciences' Lead NNRTI for HIV, RDEA806, to Enter Phase 2a Proof-of- Concept Clinical Trial
Immtech Pharmaceuticals, Inc. - Immtech Announces Pafuramidine (DB289) Program on Clinical Hold
Influenza - Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
Legionnaire Disease - Making hospitals safer from infection
Lung Cancer - Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases
Marketing and Licensing Agreements - Noven Announces FDA Tentative Approval of Stavzor(TM) Valproic Acid Delayed Release Capsules
Non-Hodgkin Lymphoma - Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
Obsessive-Compulsive Disorder - FDA Issues Approvable Letter for LUVOX(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder LEF
Osteoporosis - Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
Palomar Medical Technologies Inc - Palomar and Gillette Extend Launch Decision on Home-Use Light Based Hair Removal Device and Agree to Negotiate New Terms
Patents - U.S. District Court Decision About Eisai's Legal Action Over Aricept ODT(R) ANDA Filing
Perrigo Company - Perrigo Announces FDA Approval for Over-The-Counter Cetirizine Hydrochloride Tablets
Regulatory Actions - Mylan Announces Final FDA Approval for Balsalazide Disodium Capsules
Regulatory Actions - Mylan Announces Final FDA Approval for Cetirizine Hydrochloride Tablets
Regulatory Actions - Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Tablets (OTC), 5mg and 10mg
RNA Research - AVI BioPharma Announces Commencement of Dosing in Clinical Trial for Duchenne Muscular Dystrophy
Three Palm Software - Three Palm Software Receives FDA 510(k) Clearance for Its WorkstationOne(TM) Breast Imaging Workstation
XTENT, Inc. - XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
